Block 4 Flashcards
2 defense mechanisms of respiratory tract
Mucociliary blanket
Temperature Gradient
Temperature Gradient
There is a temperature gradient between the nasal passage (33 C) and the alveoli (37) that plays an important role in the localization of infection. Thus, rhinoviruses, which infect the nasopharynx and caue the common cold, replicate well at 33 C but grow poorly at 37 C, while influenza virus, which infects the lower respiratory tract, shows the inverse temperature preference.
Pattern Recognition Receptors (PRR)
viral surface receptors that recognize specific pathogen-associated molecular patterns (PAMPs), which are macromolecules present in virus and othe microbes, but not on host cell. One class of PRRs are Toll-like receptors (TLRs)
T/F Interferons show no virus specificity
True
T/F DNA viruses are stronger inducers of interferons than RNA Viruses
FALSE: RNA viruses are stronger inducers
How should interferons be administered to a patient?
Parenteral route (injection) because they are glycoproteins
Interferons
A group of cytokines (complex glycoproteins) that are secreted by somatic cells in response to viral infections and to other stimuli. They possess potent antiviral, immunomodulating and anticancer properties
IFN-a
Leukocyte interferon. Produced in large quantities by plasmacytoid dendritic cells
What produces Type II interferons?
Antigen-stimulated T cells and Natural Killer (NK) cells
IFN-B
Fibroblast interferon. Secreted by virus-infected fibroblast.
IFN-y
Only type of Type II Interferon
When are Type III interferons expressed?
In response to viral infections and activation of TLRs
3 types of Type III Interferons
k
Primary function of Type III interferons
Immunoregulator
Purpose of IFN-y
Mostly immunoregulatory (Type II)
What mediates humoral immunity
Antibodies released from B lymphocytes
What mediates cellular immunity
T lymphocytes
What elicits Cellular Mediated Immune (CMI) response? (2)
Internal viral antigens
Surface antigens (+ humoral response)
What can antibodies be directed against? (2)
1) Viral proteins on free virions (capsid or envelope)
2) Viral proteins expressed on surface of infected cell
Virus Neutralization
Neutralizing antibodies prevent virus attachment and entry into host cells. They bind to the viral capsid or host envelope.
Opsonization
Coating of virions with antibodies. Antibody coated virion is recognized and phagocytosed by macrophages, and sometimes by neutrophils.
Antigenic Plasticity
Rapid changes in the structure of the viral antigen. May be result of mutation, resassortment or recombination.
Due to change in antigen structure, the virus may become resistant to immunity generated by previous infection.
Antigenic Multiplicity
Antigenic variants with little or no cross-reactivity
Virokines
Some viruses synthesize proteins which are homologs of cytokines/interferons
Viroceptors
Some viruses encode proteins that are homologous to the receptors for cytokines. Serves as a competitive agonist.
Virus epidemiology
The study of the determinants, frequency, dynamics, and distribution of viral diseases in populations
Case Fatality Rate
The number (%) of deaths among the clinically ill animals
Mortality Rate
The number (%) of animals in a population that die from a particular disease over a specified period of time
Morbidity Rate
The percentage of animals in a population that develop clinical signs attributable to a particular virus over a defined period of time (commonly the duration of an outbreak)
Incidence
The number of new cases that occur in a population over a specified period of time.
Incidence/Attack Rate
A measure of the occurence of infection or disease in a population over time–for example, a month or a year, and is especially useful for describing acute diseases of short duration
Prevalence
The number of occurrences of disease (old and new cases), infection, or related attributes (antibodies) in a population, at a particular point of time
Sporadic viral diseases
Viral diseases occurring occasionally, singly, or in scattered instances, and in a irregular and haphazard manner
Enzootic viral diseases (endemic in humans)
The constant presence of a viral disease within a given geographic area or population group
Epizootic viral diseases (epidemic in humans)
The occurrence of more cases of viral diseases than expected in a given area or among a specific roup of people/animals over a particular period of time. Refers to peaks in disease incidence that exceed the endemic/enzootic baseline or expected incidence of disease.
Panzootic viral diseases (pandemic in humans)
A virus epidemic occurring over a very wide area (several countries or continents) and usually affecting a large proportion of the population.
Asymptomatic carrier
Animals that have contracted an infectious viral disease, but display no clinical symptoms.
Shed virus, transmitting disease to others.
Shedding of virus may be continuous or intermittent.
Incubatory (acute) carriers
Animals that shed virus during the incubation period of the disease
Convalescent (chronic) carriers
Animals that shed virus during recovery from disease
Inapparent carriers
Carrier state may exist in an animal with an infection that is inapparent throughout its course
Contagious disease
A disease that is spread from one person or organism to another by direct or indirect contact
Period of contagiousness
Refers to the time during which an infected animal sheds virus
Exotic disease
A disease not known to occur in a particular country or geographical area